Regulators Approve a New Drug That Could Be a Game-Changer For Postpartum Depression – ScienceAlert

Federal regulators have just given the green light to a second new kind of antidepressant this month, after decades of little progress combating the disease. The US Food and Drug Administration on Tuesday approved an injection branded Zulresso that is made by biotech company Sage Therapeutics. The drug, known as brexanalone, treats people who experience depression after giving birth, a condition known as post-partum depression (PPD). “This approval marks the first time a drug has been specifically approved to treat postpartum depression, providing an important new treatment option,” Tiffany Farchione, the FDA’s acting director in the division of psychiatry products, ...

Gepostet in der Kategorie Lebensweise (Anzahl der ansichten:) 5

Ähnlich Nachrichten